SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,857 | -7.2% | 33,100 | +24.3% | 0.00% | – |
| Q2 2023 | $123,778 | -74.3% | 26,619 | -74.5% | 0.00% | -100.0% |
| Q1 2023 | $482,074 | +85.5% | 104,345 | +224.4% | 0.00% | – |
| Q4 2022 | $259,861 | -99.9% | 32,161 | -19.9% | 0.00% | – |
| Q3 2022 | $222,838,000 | +25.9% | 40,151 | +18.2% | 0.00% | – |
| Q2 2022 | $176,932,000 | -18.7% | 33,960 | +28.3% | 0.00% | – |
| Q1 2022 | $217,624,000 | -14.0% | 26,475 | +55.6% | 0.00% | – |
| Q4 2021 | $253,124,000 | +27.4% | 17,011 | +61.8% | 0.00% | – |
| Q3 2021 | $198,609,000 | +136.8% | 10,514 | +133.0% | 0.00% | – |
| Q2 2021 | $83,878,000 | -86.9% | 4,512 | -83.9% | 0.00% | -100.0% |
| Q1 2021 | $638,509,000 | +378.8% | 28,054 | +356.8% | 0.00% | – |
| Q4 2020 | $133,343,000 | +114.5% | 6,142 | -0.7% | 0.00% | – |
| Q3 2020 | $62,179,000 | +866.6% | 6,187 | +646.3% | 0.00% | – |
| Q2 2020 | $6,433,000 | -81.4% | 829 | -75.5% | 0.00% | – |
| Q1 2020 | $34,496,000 | +29.2% | 3,382 | +39.3% | 0.00% | – |
| Q4 2019 | $26,708,000 | +131.2% | 2,428 | +91.0% | 0.00% | – |
| Q3 2019 | $11,553,000 | -14.0% | 1,271 | +7.6% | 0.00% | – |
| Q2 2019 | $13,440,000 | -22.2% | 1,181 | -22.1% | 0.00% | – |
| Q1 2019 | $17,267,000 | – | 1,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |